 Connection
Jean Mulcahy Levy to Brain Neoplasms
This is a "connection" page, showing publications Jean Mulcahy Levy has written about Brain Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.581 |
|
|
|
-
Zahedi S, Riemondy K, Liu T, Griesinger AM, Donson AM, Apfelbaum AA, Fu R, Grandvallet Contreras J, Crespo M, DeSisto J, Groat MM, Bratbak E, Green A, Hankinson TC, Handler M, Vibhakar R, Willard N, Foreman NK, Phang T, Mulcahy Levy J. Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations. Brain Pathol. 2025 Nov; 35(6):e70023.
Score: 0.462
-
Zahedi S, Fitzwalter BE, Morin A, Grob S, Desmarais M, Nellan A, Green AL, Vibhakar R, Hankinson TC, Foreman NK, Mulcahy Levy JM. Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells. Cell Death Dis. 2019 09 12; 10(9):679.
Score: 0.309
-
Mulcahy Levy JM, McMahon M. Linking brain tumors and epileptic seizures. Nat Med. 2018 11; 24(11):1638-1639.
Score: 0.291
-
Kleinschmidt-DeMasters BK, Mulcahy Levy JM. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol. 2018 Mar/Apr; 37 (2018)(2):53-63.
Score: 0.278
-
Mulcahy Levy JM, Zahedi S, Griesinger AM, Morin A, Davies KD, Aisner DL, Kleinschmidt-DeMasters BK, Fitzwalter BE, Goodall ML, Thorburn J, Amani V, Donson AM, Birks DK, Mirsky DM, Hankinson TC, Handler MH, Green AL, Vibhakar R, Foreman NK, Thorburn A. Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. Elife. 2017 01 17; 6.
Score: 0.257
-
Lyons AT, Haizel-Cobbina J, Levine A, Bishay AE, Jew N, Li C, Patil P, Bennett J, Siddaway R, Yuditskiy R, Son A, Nakano Y, Patel PG, Ku M, Velázquez JE, Schniederjan MJ, Erker C, Cacciotti C, Santi M, Nelson EJ, Cheng S, Dunham C, Wilson B, Black K, van Landeghem FKH, Eisenstat DD, Guerreiro Stücklin AS, Weiser A, Larouche V, Giannakouros P, Fonseca A, Williamson L, Fernandes IL, Plant-Fox AS, Fleming AJ, Campbell S, Mushtaq N, Bukhari SI, Minhas K, Graham RT, Raskin S, Cvrlje FJ, Ludlow LE, Mulcahy Levy JM, Yamasaki K, Suzuki T, Ohka F, Arakawa Y, Ishihara T, Yamasaki F, Hansford JR, Luck A, Nasrallah MP, Toledano H, Masoud RM, Lassaletta A, Blasco-Santana L, Kilday JP, Talianski A, Davies HC, Johnston JM, Hale AT, Dirks PB, Rutka JT, Tabori U, Hawkins CE, Dewan MC. Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality. J Neurosurg Pediatr. 2025 Dec 12; 37(2):133-146.
Score: 0.119
-
Xing YL, Panovska D, Park JW, Grossauer S, Koeck K, Bui B, Nasajpour E, Nirschl JJ, Feng ZP, Cheung P, Habib P, Wei R, Wang J, Thomason W, Monje M, Xiu J, Beck A, Weber KJ, Harter PN, Lim M, Mahaney KB, Prolo LM, Grant GA, Ji X, Walsh KM, Mulcahy Levy JM, Hambardzumyan D, Petritsch CK. BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma. Cell Rep Med. 2025 Jun 17; 6(6):102183.
Score: 0.115
-
Gilani A, Willard N, Mulcahy Levy JM, Skaugen J, Toland A. Are PDFGRA Dinucleotide Alterations Definitional for Myxoid Glioneuronal Tumor? Report of PDFRA p. K385L Mutation in a Neonatal High-Grade Glioma. Pediatr Dev Pathol. 2025 Mar-Apr; 28(2):126-132.
Score: 0.111
-
DeSisto J, Donson AM, Griesinger AM, Fu R, Riemondy K, Mulcahy Levy J, Siegenthaler JA, Foreman NK, Vibhakar R, Green AL. Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma. Neuro Oncol. 2024 03 04; 26(3):538-552.
Score: 0.105
-
Grob ST, Miller KR, Sanford B, Donson AM, Jones K, Griesinger AM, Amani V, Foreman NK, Liu A, Handler M, Hankinson TC, Milgrom S, Levy JMM. Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors. J Neurooncol. 2023 Oct; 165(1):161-169.
Score: 0.103
-
Lind KT, Chatwin HV, DeSisto J, Coleman P, Sanford B, Donson AM, Davies KD, Willard N, Ewing CA, Knox AJ, Mulcahy Levy JM, Gilani A, Green AL. Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation. J Neuropathol Exp Neurol. 2021 12 29; 80(12):1099-1107.
Score: 0.091
-
Lake JA, Donson AM, Prince E, Davies KD, Nellan A, Green AL, Mulcahy Levy J, Dorris K, Vibhakar R, Hankinson TC, Foreman NK, Ewalt MD, Kleinschmidt-DeMasters BK, Hoffman LM, Gilani A. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors. Pediatr Blood Cancer. 2020 01; 67(1):e28028.
Score: 0.078
-
Sin-Chan P, Mumal I, Suwal T, Ho B, Fan X, Singh I, Du Y, Lu M, Patel N, Torchia J, Popovski D, Fouladi M, Guilhamon P, Hansford JR, Leary S, Hoffman LM, Mulcahy Levy JM, Lassaletta A, Solano-Paez P, Rivas E, Reddy A, Gillespie GY, Gupta N, Van Meter TE, Nakamura H, Wong TT, Ra YS, Kim SK, Massimi L, Grundy RG, Fangusaro J, Johnston D, Chan J, Lafay-Cousin L, Hwang EI, Wang Y, Catchpoole D, Michaud J, Ellezam B, Ramanujachar R, Lindsay H, Taylor MD, Hawkins CE, Bouffet E, Jabado N, Singh SK, Kleinman CL, Barsyte-Lovejoy D, Li XN, Dirks PB, Lin CY, Mack SC, Rich JN, Huang A. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor. Cancer Cell. 2019 07 08; 36(1):51-67.e7.
Score: 0.076
-
Yang MJ, Whelan R, Madden J, Mulcahy Levy JM, Kleinschmidt-DeMasters BK, Hankinson TC, Foreman NK, Handler MH. Intracranial Ewing sarcoma: four pediatric examples. Childs Nerv Syst. 2018 03; 34(3):441-448.
Score: 0.069
-
Green AL, Mulcahy Levy JM, Vibhakar R, Hemenway M, Madden J, Foreman N, Dorris K. Tumor treating fields in pediatric high-grade glioma. Childs Nerv Syst. 2017 Jul; 33(7):1043-1045.
Score: 0.066
-
Mulcahy Levy JM, Foreman NK, Thorburn A. Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors. Autophagy. 2014; 10(11):2077-8.
Score: 0.052
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|